About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Texas | 42,045 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 42,045 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4261-4280 of 42,045 trials

CompletedS9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00004137·Mobile, Alabama and 84 others

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

CompletedZanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) TreatmentThe primary objective of this study is to evaluate the safety of zanubrutinib (also known as BGB-3111) in chronic lymphocytic leukemia/small lymphocytic lymphoma, Waldenström…NCT04116437·Aurora, Colorado and 23 others

TerminatedClazosentan in Aneurysmal Subarachnoid HemorrhageThe aim of this study is to demonstrate that clazosentan, administered as a continuous intravenous infusion at either 5 mg/h or 15 mg/h until Day 14 post aneurysmal subarachnoid…NCT00940095·Glendale, California and 144 others

Active not recruitingProspective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational DeviceThis is a prospective, multi-center image case collection study to acquire de-identified contrast-enhanced breast images on a mammography device to support continuing software…NCT06636539·Houston, Texas and 1 other

CompletedXIENCE 28 USA StudyThe XIENCE 28 USA Study is prospective, single arm, multi-center, open label, non-randomized trial to evaluate safety of 1-month (as short as 28 days) dual antiplatelet therapy…NCT03815175·Huntsville, Alabama and 110 others

CompletedTesting the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF)This is a study to examine the effect of combining chronic oral azithromycin with inhaled tobramycin in adolescent and adult subjects with cystic fibrosis who are chronically…NCT02677701·Los Angeles, California and 38 others

CompletedRituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)This double-blind randomized, parallel group study will evaluate the efficacy and safety of lenalidomide (Revlimid, CC-5013) in combination with rituximab (MabThera/Rituxan) in…NCT01938001·Mobile, Alabama and 159 others

TerminatedA Study in Participants With Diabetic Kidney DiseaseThe purpose of this study is to determine if LY2382770 is safe and effective at protecting kidney function in participants with kidney disease due to diabetes.NCT01113801·Phoenix, Arizona and 77 others

TerminatedEffect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid EndarterectomyThe purpose of this study is to determine, in patients undergoing carotid endarterectomy, the effect of ARC1779 Injection on the number of microembolic signals detected by…NCT00742612·Hackensack, New Jersey and 6 others

CompletedBrexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant TreatmentTo evaluate the long-term efficacy and safety of brexpiprazole as an adjunctive treatment to an antidepressant treatment (ADT) for adult patients with Major Depressive Disorder…NCT01838681·Little Rock, Arkansas and 106 others

CompletedIntrathecal MafosfamideThis research study is an investigational treatment with the experimental drug Mafosfamide.NCT00062881·Los Angeles, California and 9 others

RecruitingTransplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart RecipientsThis phase II, multi-center, open-label study will evaluate the safety and efficacy of utilizing HCV-positive donors for heart transplant in HCV-negative recipients treated with…NCT03383419·Los Angeles, California and 2 others

CompletedRegimen for the Treatment of Cachexia in Subjects With NSCLCCachexia is a presentation of a chronic manifestation of acute metabolic stress, a hypercatabolic nutritional state in which the normal fat and protein sparing mechanisms are not…NCT00527319·Waco, Texas and 7 others

CompletedMetabolomics for Biomarker Discovery in Children With EoEThe investigators are seeking to enroll 8 children ages 2-18 already undergoing upper endoscopy.NCT03107819·Houston, Texas

CompletedBioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With CobicistatThe purpose of the study is to compare the pharmacokinetics and bioequivalence of atazanavir in a fixed-dose combination with cobicistat with that of atazanavir coadministered…NCT01837719·Austin, Texas

Active not recruitingA Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)This is a Phase 3, global, randomized, open-label, multicenter trial designed to evaluate the safety and efficacy of chronic treatment with brelovitug (BJT-778) for chronic…NCT07298330·Davis, California and 26 others

TerminatedA Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLLThis study is to evaluate the safety and clinical activity of idelalisib alone and in combination with rituximab in patients with CLL or SLL.NCT01203930·La Jolla, California and 5 others

TerminatedA Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)Researchers are looking for a new way to treat people with non-segmental vitiligo (NSV).NCT06113328·Birmingham, Alabama and 67 others

Enrolling by invitationReducing G60 Recidivism RatesThe research surrounding best practice guidelines of geriatric trauma patients in the inpatient setting is broad.NCT05224765·Dallas, Texas

CompletedEvaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid TumorsThe purpose of this study is to evaluate the safety and tolerability of IV administration of VX15/2503 in patients with advanced solid tumors.NCT01313065·Scottsdale, Arizona and 1 other

PreviousPage 214 of 2103Next

Heart Diseasein Texas